Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUDRO-SHOCK
NCT07898462Phase 3Recruiting
- Sponsor
- The George Institute for Global Health
- Start
- Oct 2026
- Primary completion
- Mar 2030
- Countries
- 1
01
Overview
A Phase 3 trial of fludrocortisone in septic shock, sponsored by The George Institute for Global Health. Started Oct 2026; status: recruiting.
02
Drugs
fludrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07898462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07898462.